AnteoTech Limited (ASX:ADO)

Australia flag Australia · Delayed Price · Currency is AUD
0.0400
+0.0050 (14.29%)
May 28, 2026, 1:33 PM AEST
Market Cap104.06M +380.8%
Revenue (ttm)405.76K +110.4%
Net Income-5.97M
EPS-0.00
Shares Out 2.97B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41,221,856
Open0.0340
Previous Close0.0350
Day's Range0.0340 - 0.0420
52-Week Range0.0070 - 0.0490
Beta0.57
Analystsn/a
Price Targetn/a
Earnings DateFeb 24, 2026

About AnteoTech

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micr... [Read more]

Sector Materials
CEO Merrill Gray
Employees 99
Stock Exchange Australian Securities Exchange
Ticker Symbol ADO
Full Company Profile

Financial Performance

In fiscal year 2025, AnteoTech's revenue was 968,878, an increase of 110.44% compared to the previous year's 460,397. Losses were -6.76 million, -23.89% less than in 2024.

Financial Statements

News

AnteoTech Slides: Investor presentation

AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on April 22, 2026.

5 weeks ago - Filings

AnteoTech Slides: Q3 2026

AnteoTech has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on April 21, 2026.

5 weeks ago - Filings

AnteoTech Earnings release: Q3 2026

AnteoTech released its Q3 2026 earnings on April 21, 2026, summarizing the period's financial results.

5 weeks ago - Filings

AnteoTech Transcript: NWR Virtual Healthcare Conference

The business is focused on in vitro diagnostics, targeting new product development with AnteoBind NXT, and expanding into the chemiluminescence market. Strategic partnerships, increased sales efforts, and progress with a major life sciences company are key catalysts for growth in the next year.

2 months ago - Transcripts

AnteoTech Slides: NWR Virtual Healthcare Conference

AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.

2 months ago - Filings

AnteoTech Slides: Investor presentation

AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

AnteoTech Earnings Call Transcript: H1 2026

Streamlined operations and a successful AUD 3.5M capital raise have positioned the company for growth, with a strong sales pipeline in batteries and life sciences, and targeted expansion in the US, South Korea, and India.

3 months ago - Transcripts

AnteoTech Quarterly report: H1 2026

AnteoTech has published its H1 2026 quarterly earnings report on March 1, 2026.

3 months ago - Filings

AnteoTech Slides: H1 2026

AnteoTech has posted slides in relation to its H1 2026 quarterly earnings report, which was published on March 1, 2026.

3 months ago - Filings

AnteoTech Earnings release: Q2 2026

AnteoTech released its Q2 2026 earnings on January 28, 2026, summarizing the period's financial results.

4 months ago - Filings

AnteoTech Slides: Investor Presentation

AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on December 11, 2025.

5 months ago - Filings

AnteoTech Transcript: AGM 2025

The AGM highlighted strong revenue growth, successful product launches, and strategic expansion into new markets. All resolutions passed except the spill motion, with shareholders expressing confidence in the board and management's direction.

6 months ago - Transcripts

AnteoTech Slides: FY 2025

AnteoTech has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 25, 2025.

6 months ago - Filings

AnteoTech Earnings release: Q1 2026

AnteoTech released its Q1 2026 earnings on October 26, 2025, summarizing the period's financial results.

7 months ago - Filings

AnteoTech Earnings Call Transcript: H2 2025

Cost reductions and doubled revenue marked the year, with accelerated R&D rebates and strong commercial focus. High-silicon battery milestones and expanded global partnerships drive growth, while complex supply chains and long sales cycles remain key challenges.

9 months ago - Transcripts

AnteoTech Annual report: H2 2025

AnteoTech has published its H2 2025 annual report on August 28, 2025.

9 months ago - Filings

AnteoTech Slides: H2 2025

AnteoTech has posted slides in relation to its H2 2025 quarterly earnings report, which was published on August 28, 2025.

9 months ago - Filings

AnteoTech Earnings release: Q4 2025

AnteoTech released its Q4 2025 earnings on July 29, 2025, summarizing the period's financial results.

10 months ago - Filings

AnteoTech Slides: Investor Presentation

AnteoTech has posted slides in relation to its latest quarterly earnings report, which was published on June 25, 2025.

1 year ago - Filings